InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-7.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Migausky George V, Directeur. Officer active across 3 companies, notably Immunovant, Inc.. Cumulatively, 25 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €195k. History available since 20 August 2021. The latest transaction was disclosed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Migausky George V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
7,768 shares0Common StockSEC:0001562180-25-004350:0
16,188 shares0Common StockSEC:0001764013-25-000041:0
4,790 shares0Common StockSEC:0001562180-24-004655:0
11,255 shares0Common StockSEC:0001764013-24-000063:0
4,200 shares@ US$38.7962.0% of flowCommon StockSEC:0001764013-23-000153:0
3,486 shares0Common StockSEC:0001562180-23-004892:0
12,523 shares0Common StockSEC:0001764013-23-000044:0
21,059 shares0Common StockSEC:0001764013-22-000093:0
3,010 shares0Common StockSEC:0001562180-22-004879:0
21,726 shares0Common StockSEC:0001764013-22-000019:0
7,000 shares@ US$7.6523.5% of flowCommon StockSEC:0001764013-21-000090:0
Canonical exit: 18 Nov 2021 (T+90)
751,975 sharesCommon StockSEC:0000908662-16-000437:0
15,000 sharesCommon StockSEC:0000908662-16-000437:1
42,734 sharesCommon StockSEC:0000908662-16-000404:0
87,729 sharesCommon StockSEC:0000908662-16-000404:1
50,007 sharesCommon StockSEC:0000908662-16-000404:2
91,042 sharesCommon StockSEC:0000908662-16-000404:3
39,999 sharesCommon StockSEC:0000908662-16-000404:4
15,000 sharesCommon StockSEC:0000908662-16-000404:5
62,500 sharesCommon StockSEC:0000908662-16-000404:6
142,239 sharesCommon StockSEC:0000908662-16-000390:0
12,266 sharesCommon StockSEC:0000908662-16-000381:0
37,271 sharesCommon StockSEC:0000908662-16-000381:1
47,761 sharesCommon StockSEC:0000908662-16-000381:2
52,077 sharesCommon StockSEC:0000908662-16-000381:3
25 of 25 declarations
About Migausky George V
MIGAUSKY GEORGE V is a Director and has 25 filings in total. In the 25 sampled filings, dated from 2016-01-08 to 2025-06-03, the recorded amounts are EUR 45861 in buys and EUR 149575 in sells, and the modal transaction nature is listed as Exercise of options. He is linked to DYAX CORP as EVP & Chief Financial Officer, to Immunovant, Inc. as Director, and to REGENXBIO Inc. as Director.
